ACTRN12614001018606已完成未知
A preliminary examination of the Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure - Adolescent (COPE-A) intervention: Designed to reduce traumatic stress symptoms and substance use among adolescents aged 12-17yrs
Mental Health and Drug and Alcohol Office (MHDAO)0 个研究点目标入组 10 人开始时间: 2014年9月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 12 Years 至 17 Years（—）
- 性别
- All
入选标准
- •(i) aged between 12-17 years,
- •(ii) substance use in the past month,
- •(iii) lifetime exposure to at least one traumatic event,
- •(iv) partial or full diagnosis of current PTSD.
排除标准
- •(i) recent history of suicide or self-harm,
- •(ii) chronic psychosis,
- •(iii) organic or traumatic brain injury, or
- •(iv) ongoing trauma-related threat or ongoing unsupervised contact with the alleged perpetrator.
研究者
相似试验
招募中
不适用
Effectiveness of Unified Protocol in Anxiety DisordersCTRI/2021/01/030803niversity Grants Commission
已完成
不适用
A Preliminary Evaluation of an Acceptance and Commitment Therapy Based Program for Adult Congenital Heart Disease Patients.resiliencestressquality of lifeAdult congenital heart diseaseMental Health - DepressionMental Health - AnxietyCardiovascular - Other cardiovascular diseasesanxietydepressionACTRN12614000425695The Prince Charles Hospital30
已完成
2 期
CEREBRAL PALSY IN CHILDREN.CTRI/2015/07/006038Institute for Post Graduate Teaching and Research in Ayurveda jamnagar20
进行中（未招募）
1 期
The CONFRONT Phase I – II Trial: ACtivatiON oF immune RespONse in paTients with R-M Head and Neck Cancer. Multimodality immunotherapy with Avelumab, short course radiotherapy and Cyclophosphamide in Head and Neck cancer.R-M Head and Neck CancerMedDRA version: 20.0Level: PTClassification code 10034813Term: Pharyngeal cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10055104Term: Pharyngeal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000353-39-ITG.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST71
已完成
不适用
A PHASE II PROSPECTIVE TRIAL CORRELATING THE PROGRESSION FREE SURVIVAL CYP2D6 WITH ACTIVITY IN PATIENTS WITH METASTATIC BREAST CANCER TREATED WITH SINGLE AGENT TAMOXIFE-C61 Malignant neoplasm of prostateMalignant neoplasm of prostateC61PER-114-10EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG), GRUPO DE ESTUDIOS CLINICOS ONCOLOGICO DEL PERU GECOPERU,37